SCM
CORZ icon

Sandler Capital Management’s Core Scientific CORZ Stock Holding History

Sandler Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-171,071
Closed -$2.51M – 152
2025
Q2 		$2.92M Buy
+171,071
New +$1.71M 0.79% 48

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

Sandler Capital Management's CORZ Position: Q3 2025 in Review

Sandler Capital Management sold out of Core Scientific (CORZ) in Q3 2025, closing a stake of 171,071 shares — an estimated $2.51M sold.

Sandler Capital Management first reported a position in CORZ in Q2 2025 and held it in 1 quarter. The position peaked at $2.92M in Q2 2025. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Sandler Capital Management reported no remaining Core Scientific position as of Q3 2025 after selling out during the quarter.
  • Sandler Capital Management sold 171,071 Core Scientific shares in Q3 2025, an estimated $2.51M.
  • Sandler Capital Management first reported a position in Core Scientific in Q2 2025 and held it in 1 quarter.
  • Sandler Capital Management's Core Scientific position peaked at $2.92M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Sandler Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.